Economics, Patents Critical for Pharmaceuticals Innovation, Equity Prices

The S&P 500 Health Care Index is up 18% year-to-date, an admiral though not spectacular performance. While coronavirus vaccines remain a point of much discussion, pharmaceuticals stocks also fit the bill as solid though not spectacular. However, there are still reasons to consider exchange...